Yes, a new combination or even just a reformulation can become the new SOC and kill off a generic.
BTW, reformulation of a generic is IXC's business model.
Ann: Expanded Heart Protection Discovery for Zantrene, page-148
-
- There are more pages in this discussion • 239 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.95 |
Change
0.065(3.45%) |
Mkt cap ! $327.8M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $305.4K | 160.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1569 | $1.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 3853 | 1 |
View Market Depth
| Last trade - 15.05pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |